A Study of PF-06873600 in People With Breast and Ovarian Cancer
PHASE 1/2A DOSE ESCALATION AND EXPANSION STUDY EVALUATING SAFETY, TOLERABILITY, PHARMACOKINETIC, PHARMACODYNAMICS AND ANTI-TUMOR ACTIVITY OF PF-06873600 AS A SINGLE AGENT AND IN COMBINATION WITH ENDOCRINE THERAPY
Category & Conditions: Cancer
Medicine: PF-06873600
ClinicalTrials.gov Identifier (NCT): NCT03519178
Protocol ID: C3661001
PrintDownloadOpen Plain Language Summary Result: Click here